Pik3ca Mutation-related Tumors
📧 Sign up to get email alerts when something new happens for Pik3ca Mutation-related Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-11-15Clinical Trial Update: A Study of WX390 in Patients With Advanced Solid Tumors With PIK3CA Mutations [Phase 1, Phase 2]
Clinical trial update for WX390 in patients with PIK3CA mutation-related tumors across Phase 1 and Phase 2 has completed.